SODIUM CHANNEL-BLOCKING AGENTS - THEIR USE IN NEUROPATHIC PAIN CONDITIONS

被引:0
|
作者
TANELIAN, DL [1 ]
VICTORY, RA [1 ]
机构
[1] UNIV TEXAS,SW MED CTR,DEPT ANESTHESIOL & PAIN MANAGEMENT,PAIN RES PROGRAM,DALLAS,TX 75235
来源
PAIN FORUM | 1995年 / 4卷 / 02期
关键词
NEUROPATHIC PAIN; CHRONIC PAIN; MEXILETINE; CARBAMAZEPINE; PHENYTOIN; LOCAL ANESTHETICS; LIDOCAINE; PROCAINE;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neuropathic pain conditions are due to damage or permanent alteration of the peripheral or central nervous system. These conditions are generally chronic and less responsive to opiates than nociceptive (acute) pain conditions; as such, they are very difficult to treat clinically. Numerous classes of drugs, including opiates, antidepressants, anticonvulsants, local anesthetics, antiarrhythmics, steroids, antipsychotic agents, and topical capsaicin have been used to treat neuropathic pain. One mechanism common to several of these pharmacological agents is their ability to block sodium channels in a use-dependent fashion. In this focus article clinical evidence of the effectiveness of sodium channel-blocking drugs for relieving neuropathic pain will be presented. Experimental evidence for the site of action of these drugs will be discussed, along with future studies that are needed to develop new, more effective, agents.
引用
收藏
页码:75 / 80
页数:6
相关论文
共 50 条
  • [21] Frontline Sodium Channel-Blocking Antiseizure Medicine Use Promotes Future Onset of Drug-Resistant Chronic Seizures
    Zierath, Dannielle
    Mizuno, Stephanie
    Barker-Haliski, Melissa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [22] The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis
    Nelson, Michaela
    Yang, Ming
    Dowle, Adam A.
    Thomas, Jerry R.
    Brackenbury, William J.
    MOLECULAR CANCER, 2015, 14
  • [23] The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis
    Michaela Nelson
    Ming Yang
    Adam A Dowle
    Jerry R Thomas
    William J Brackenbury
    Molecular Cancer, 14
  • [24] NEW SODIUM CHANNEL-BLOCKING CONOTOXINS ALSO AFFECT CALCIUM CURRENTS IN LYMNAEA NEURONS
    FAINZILBER, M
    VANDERSCHORS, R
    LODDER, JC
    LI, KW
    GERAERTS, WPM
    KITS, KS
    BIOCHEMISTRY, 1995, 34 (16) : 5364 - 5371
  • [25] Novel sodium channel antagonists in the treatment of neuropathic pain
    Rivara, Mirko
    Zuliani, Valentina
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (02) : 215 - 226
  • [26] Are sodium channel blockers useless in peripheral neuropathic pain?
    Sindrup, Soren H.
    Jensen, Troels S.
    PAIN, 2007, 128 (1-2) : 6 - 7
  • [27] Which intravenous sodium channel blocker for neuropathic pain?
    Chojnowska, E
    ANESTHESIA AND ANALGESIA, 2000, 90 (04): : 1007 - 1008
  • [28] Novel sodium channel blockers for the treatment of neuropathic pain
    Marron, Brian
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 41, 2006, 41 : 59 - 73
  • [29] EFFECTS OF POTASSIUM CHANNEL-BLOCKING AGENTS ON NEURONS IN THE INFERIOR MESENTERIC GANGLION IN GUINEA-PIG
    KING, BF
    SZURSZEWSKI, JH
    JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1988, 23 (03): : 241 - 252
  • [30] THE CHARYBDOTOXIN FAMILY OF K+ CHANNEL-BLOCKING PEPTIDES
    MILLER, C
    NEURON, 1995, 15 (01) : 5 - 10